Cambridge Investment Research Advisors
IMTX icon

Cambridge Investment Research Advisors’s Immatics IMTX Stock Holding History

Cambridge Investment Research Advisors’s Portfolio IMTX Stock Details IMTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-14,717
Closed -$170K – 3205
2023
Q2 		$170K Buy
14,717
+350
+2% +$3.27K ﹤0.01% 2915
2023
Q1 		$99K Buy
+14,367
New +$118K ﹤0.01% 2968

Other funds holding IMTX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Cambridge Investment Research Advisors's IMTX Position: Q3 2023 in Review

Cambridge Investment Research Advisors sold out of Immatics (IMTX) in Q3 2023, closing a stake of 14,717 shares — an estimated $170K sold.

Cambridge Investment Research Advisors first reported a position in IMTX in Q1 2023 and held it in 2 quarters. The position peaked at $170K in Q2 2023. 74 funds tracked by Wall St. Rank hold IMTX as of Q3 2023.

  • Cambridge Investment Research Advisors reported no remaining Immatics position as of Q3 2023 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 14,717 Immatics shares in Q3 2023, an estimated $170K.
  • Cambridge Investment Research Advisors first reported a position in Immatics in Q1 2023 and held it in 2 quarters.
  • Cambridge Investment Research Advisors's Immatics position peaked at $170K in Q2 2023.
  • 74 funds tracked by Wall St. Rank held Immatics as of Q3 2023.

Based on Cambridge Investment Research Advisors's 13F filing for Q3 2023, filed 24 Oct 2023.